|
1
|
Kitson SJ, Evans DG and Crosbie EJ:
Identifying high-risk women for endometrial cancer prevention
strategies: Proposal of an endometrial cancer risk prediction
model. Cancer Prev Res (Phila). 10:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei KR, Chen WQ, Zhang SW, Zheng RS, Wang
YN and Liang ZH: Epidemiology of uterine corpus cancer in some
cancer registering areas of China from 2003–2007. Zhonghua Fu Chan
Ke Za Zhi. 47:445–451. 2012.(In Chinese). PubMed/NCBI
|
|
3
|
Esposito K, Chiodini P, Capuano A,
Bellastella G, Maiorino MI and Giugliano D: Metabolic syndrome and
endometrial cancer: A meta-analysis. Endocrine. 45:28–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruchim I, Sarfstein R and Werner H: The
IGF hormonal network in endometrial cancer: Functions, regulation,
and targeting approaches. Front Endocrinol (Lausanne).
5:762014.PubMed/NCBI
|
|
5
|
McGrath M, Lee IM, Buring J and De Vivo I:
Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3
and endometrial cancer risk. Gynecol Oncol. 120:174–178. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamanaka Y, Wilson EM, Rosenfeld RG and Oh
Y: Inhibition of insulin receptor activation by insulin-like growth
factor binding proteins. J Biol Chem. 272:30729–30734. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ricort JM: Insulin-like growth factor
binding protein (IGFBP) signalling. Growth Horm IGF Res.
14:277–286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwa V, Oh Y and Rosenfeld RG: The
insulin-like growth factor-binding protein (IGFBP) superfamily.
Endocr Rev. 20:761–787. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oh Y, Nagalla SR, Yamanaka Y, Kim HS,
Wilson E and Rosenfeld RG: Synthesis and characterization of
insulin-like growth factor-binding protein (IGFBP)-7. Recombinant
human mac25 protein specifically binds IGF-I and -II. J Biol Chem.
271:30322–30325. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhan Y, Wang J, Ma Y, Liu Z, Xu H, Lu S
and Lu B: Serum insulin-like, growth factor binding protein-related
protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women.
Int J Cancer. 132:411–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Serafim MK, Silva GM, Duarte AB, Araújo
VR, Silva TF, Lima AK, Chaves RN, Campello CC, Silva LD and
Figueiredo JR: High insulin concentrations promote the in vitro
growth and viability of canine preantral follicles. Reprod Fertil
Dev. 25:927–934. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Pacyna-Gengelbach M, Ye F, Knösel
T, Lund P, Deutschmann N, Schlüns K, Kotb WF, Sers C, Yasumoto H,
et al: Insulin-like growth factor binding protein-related protein 1
(IGFBP-rP1) has potential tumour-suppressive activity in human lung
cancer. J Pathol. 211:431–438. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vizioli MG, Sensi M, Miranda C, Cleris L,
Formelli F, Anania MC, Pierotti MA and Greco A: IGFBP7: An
oncosuppressor gene in thyroid carcinogenesis. Oncogene.
29:3835–3844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benatar T, Yang W, Amemiya Y, Evdokimova
V, Kahn H, Holloway C and Seth A: IGFBP7 reduces breast tumor
growth by induction of senescence and apoptosis pathways. Breast
Cancer Res Treat. 133:563–573. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen D, Yoo BK, Santhekadur PK, Gredler R,
Bhutia SK, Das SK, Fuller C, Su ZZ, Fisher PB and Sarkar D:
Insulin-like growth factor-binding protein-7 functions as a
potential tumor suppressor in hepatocellular carcinoma. Clin Cancer
Res. 17:6693–6701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Verhagen HJ, de Leeuw DC, Roemer MG,
Denkers F, Pouwels W, Rutten A, Celie PH, Ossenkoppele GJ,
Schuurhuis GJ and Smit L: IGFBP7 induces apoptosis of acute myeloid
leukemia cells and synergizes with chemotherapy in suppression of
leukemia cell survival. Cell Death Dis. 5:e13002014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma Y, Lu B, Ruan W, Wang H, Lin J, Hu H,
Deng H, Huang Q and Lai M: Tumor suppressor gene insulin-like
growth factor binding protein-related protein 1 (IGFBP-rP1) induces
senescence-like growth arrest in colorectal cancer cells. Exp Mol
Pathol. 85:141–145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dimri GP, Lee X, Basile G, Acosta M, Scott
G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O,
et al: A biomarker that identifies senescent human cells in culture
and in aging skin in vivo. Proc Natl Acad Sci USA. 92:9363–9367.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rosato V, Zucchetto A, Bosetti C, Dal Maso
L, Montella M, Pelucchi C, Negri E, Franceschi S and La Vecchia C:
Metabolic syndrome and endometrial cancer risk. Ann Oncol.
22:884–889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ni J, Zhu T, Zhao L, Che F, Chen Y, Shou H
and Yu A: Metabolic syndrome is an independent prognostic factor
for endometrial adenocarcinoma. Clin Transl Oncol. 17:835–839.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Swisshelm K, Ryan K, Tsuchiya K and Sager
R: Enhanced expression of an insulin growth factor-like binding
protein (mac25) in senescent human mammary epithelial cells and
induced expression with retinoic acid. Proc Natl Acad Sci USA.
92:4472–4476. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wajapeyee N, Serra RW, Zhu X, Mahalingam M
and Green MR: Oncogenic BRAF induces senescence and apoptosis
through pathways mediated by the secreted protein IGFBP7. Cell.
132:363–374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xue W, Zender L, Miething C, Dickins RA,
Hernando E, Krizhanovsky V, Cordon-Cardo C and Lowe SW: Senescence
and tumour clearance is triggered by p53 restoration in murine
liver carcinomas. Nature. 445:656–660. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dimova DK and Dyson NJ: The E2F
transcriptional network: Old acquaintances with new faces.
Oncogene. 24:2810–2826. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rowland BD and Bernards R: Re-evaluating
cell-cycle regulation by E2Fs. Cell. 127:871–874. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gil J and Peters G: Regulation of the
INK4b-ARF-INK4a tumour suppressor locus: All for one or one for
all. Nat Rev Mol Cell Biol. 7:667–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meloche S and Pouysségur J: The ERK1/2
mitogen-activated protein kinase pathway as a master regulator of
the G1- to S-phase transition. Oncogene. 26:3227–3239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amemiya Y, Yang W, Benatar T, Nofech-Mozes
S, Yee A, Kahn H, Holloway C and Seth A: Insulin like growth factor
binding protein-7 reduces growth of human breast cancer cells and
xenografted tumors. Breast Cancer Res Treat. 126:373–384. 2011.
View Article : Google Scholar : PubMed/NCBI
|
